SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-16-051941
Filing Date
2016-02-12
Accepted
2016-02-12 10:04:40
Documents
2
Group Members
PHASE4 VENTURES III GENERAL PARTNER LTDPHASE4 VENTURES III GP LPPHASE4 VENTURES III LP

Document Format Files

Seq Description Document Type Size
1 PHASE4 PARTNERS LTD SC 13G 9-23-2015 (NABRIVA THERAPEUTICS) formsc13g.htm SC 13G 136286
2 EXHIBIT A ex99_a.htm EX-99.A 10642
  Complete submission text file 0001140361-16-051941.txt   148535
Mailing Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ
Business Address GREEN PARK HOUSE 15 STRATTON STREET LONDON X0 W1J 8LQ 44 0 20 3036 0050
Phase4 Partners Ltd (Filed by) CIK: 0001600023 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89113 | Film No.: 161415611
SIC: 2834 Pharmaceutical Preparations